Neostigmine Methylsulfate Injection, Solution
Product Images NDC 76045-214

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 76045-214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Neo0i 0002 01)

FDA Label Image

Figure 1 (Neo0i 0002 02)

Figure 1 (Neo0i 0002 02)
The text appears to be a list of components included in a package. It includes a plunger rod, labeled syringe barrel, a Luer lock collar, and a syringe tip cap with a warning not to remove some of the mentioned components. These components are possibly related to a medical or laboratory setting and are designed to be used together for a specific purpose.*
FDA Label Image

Figure 2 (Neo0i 0002 03)

FDA Label Image

Figure 3 (Neo0i 0002 04)

FDA Label Image

Fresenius Kabi Logo (Neo0i 0002 05)

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
This is a description of a Neostigmine Methylsulfate Injection available in a 3 mL Single-Dose Prefilled Syringe. It is for IV use only and requires a prescription. The syringe is manufactured by Fresenius Kabi and has a concentration of 1 mg per mL. The product code is 4034148, and the item number is 01-00376045383133.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
This is a label for Neostigmine 3mgper3mL and Methyisuitate Injection, for use with a single-dose refled syringe via intravenous injection. No further information available.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
This is a description of Neostigmine 3mgper3mL Methylsulfate Injection which comes in a box of 10 x 3 mL single-dose prefilled syringes. This medication is approved for intravenous use only and should not be placed on a sterile field. Each mL contains neostigmine methylsulfate 1 mg, phenol 45 mg (as a preservative), sodium acetate (trihydrate) 0.2 mg and water for injection. The medication should be stored at 20° to 25°C (68° to 77°F) and any unused portion must be discarded. Usual Dosage is as per the package insert.*
FDA Label Image

Neo0i 0002 09

Neo0i 0002 09
This is a single-dose prefilled syringe with a capacity of 3 mL, meant for intravenous usage only and requires an Rx. The syringe contains Neostigmine 3mgper3 mL% Methylsullate Injection, USP (1 mg per mL), manufactured by Fresenius Kabi. The provided numbers (05mL 1mL 15mL 2mL 25mL 3mL) may indicate different syringe sizes available from the manufacturer, but further information is not available.*
FDA Label Image

Neo0i 0002 10

FDA Label Image

Neo0i 0002 11

Neo0i 0002 11
This is a pharmaceutical product containing Neostigmine Methylsulfate Injection, USP (1mg per mL) in single-dose prefilled syringes. It is for intravenous use only and should not be placed on a sterile field. Each mL contains neostigmine methylsulfate, phenol, sodium acetate, and water for injection. The product has usual dosages specified in-package inserts and should be stored at a controlled room temperature. The package comes in prefilled syringes, and any unused portion should be discarded.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.